Web Images Videos News

Axumin.com

Axumin is a radioactive diagnostic agent for positron emission tomography (PET) imaging of men with suspected prostate cancer recurrence.

Axumin - FDA prescribing information, side effects and uses

Axumin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

FDA approves new diagnostic imaging agent to detect ...

Axumin is indicated for positron emission tomography ... FDA approves new diagnostic imaging agent to detect recurrent prostate cancer. Share; Tweet; Linkedin;

Axumin approved for use in PET scans in patients with ...

Two studies evaluated the safety and efficacy of Axumin for imaging prostate cancer in patients with recurrent disease. The first compared 105 Axumin scans ...

Axumin (Fluciclovine F 18 Intravenous Injection): Side ...

Axumin is a sterile, non-pyrogenic, clear, colorless, hyperosmolal (approximately 500 - 540 mOsm/kg) injection for intravenous use. Each milliliter contains up to 2 ...

Reference ID: 3937715

Axumin is not indicated for use in females and there is no information of the presence of fluciclovine F 18 in human milk. Page . 4 . of . 8 . Reference ID: 3937715 . 18.

Drug Trails Snapshots: Axumin

DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? AXUMIN is a drug for detection of prostate cancer recurrence in men who have been treated for prostate ...

Studies That Led to FDA Approval of Axumin as Prostate ...

Read about Blue Earth Diagnostics presentation of studies that led to FDA approval of molecular imaging agent Axumin to identify prostate cancer recurrence.

Axum - Wikipedia

Axum was the center of the marine trading power known as the Aksumite Kingdom, which predated the earliest mentions in Roman era writings. Around 356 CE ...